Shares of Tenet Healthcare Corp (NYSE:THC) have received an average recommendation of “Hold” from the fifteen brokerages that are presently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $29.45.
Several analysts have weighed in on the company. Barclays set a $24.00 price target on Tenet Healthcare and gave the company a “hold” rating in a report on Wednesday, April 17th. SunTrust Banks raised their price target on Mcdonald’s to $230.00 and gave the company a “buy” rating in a report on Wednesday, May 1st. TheStreet raised White Mountains Insurance Group from a “c” rating to a “b” rating in a report on Monday, May 13th. Finally, ValuEngine cut Zosano Pharma from a “buy” rating to a “hold” rating in a report on Wednesday, May 1st.
Several hedge funds have recently modified their holdings of THC. Norges Bank bought a new stake in shares of Tenet Healthcare in the 4th quarter worth approximately $23,500,000. FMR LLC boosted its position in shares of Tenet Healthcare by 64.3% during the fourth quarter. FMR LLC now owns 1,569,517 shares of the company’s stock valued at $26,902,000 after purchasing an additional 614,397 shares in the last quarter. Orbimed Advisors LLC bought a new stake in shares of Tenet Healthcare during the fourth quarter valued at approximately $9,646,000. Acadian Asset Management LLC boosted its position in shares of Tenet Healthcare by 72.7% during the first quarter. Acadian Asset Management LLC now owns 1,074,895 shares of the company’s stock valued at $30,997,000 after purchasing an additional 452,346 shares in the last quarter. Finally, Deutsche Bank AG boosted its position in shares of Tenet Healthcare by 41.6% during the fourth quarter. Deutsche Bank AG now owns 1,080,533 shares of the company’s stock valued at $18,519,000 after purchasing an additional 317,432 shares in the last quarter. Hedge funds and other institutional investors own 99.16% of the company’s stock.
Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Monday, April 29th. The company reported $0.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.25. Tenet Healthcare had a positive return on equity of 29.29% and a negative net margin of 0.04%. The business had revenue of $4.55 billion for the quarter, compared to analysts’ expectations of $4.51 billion. During the same quarter in the prior year, the firm posted $0.57 EPS. The firm’s quarterly revenue was down 3.3% on a year-over-year basis. Equities analysts predict that Tenet Healthcare will post 2.33 earnings per share for the current year.
Tenet Healthcare Company Profile
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Featured Story: What are the risks of holding treasury bonds?
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.